文献速递临床试验与 GCP

电针缓解急性胰腺炎腹痛的随机对照试验研究方案

Electroacupuncture for abdominal pain relief in patients with acute pancreatitis: study protocol for a randomized controlled trial.
PubMed 文献 · Trials · 2018-05-16

本研究为随机、对照、三臂、平行组、多中心试验,纳入急性胰腺炎患者按1:1:1随机分为局部电针组、局部加远端电针组和对照组,所有患者均接受常规标准治疗。主要终点为第5天疼痛视觉模拟量表(VAS)变化,旨在验证电针缓解急性胰腺炎腹痛的疗效。

要点

  • 电针组每日一次从第1天至第4天或至疼痛缓解。
  • 主要终点为第5天VAS疼痛变化。
  • 所有患者均接受急性胰腺炎常规标准治疗。

核心结论

  • 本试验结果预期证明电针缓解急性胰腺炎患者腹痛的疗效,基于结果电针可应用于减少疼痛的多种临床实践。

研究设计与样本

  • 随机、对照、三臂、平行组、多中心试验,患者按1:1:1随机分为EA 1、EA 2或对照组。
  • 所有入组患者基本接受急性胰腺炎常规标准治疗。

关键数值与推荐

  • 主要终点为第5天疼痛视觉模拟量表(VAS)变化。
  • 次要终点包括每日VAS、镇痛药需求、炎症标志物变化、疼痛消失时间和住院天数。
  • EA 1组给予局部电针,EA 2组给予局部加远端电针;局部电针包括中脘(CV12)和上脘(CV13),远端电针包括12个外周穴位:中脘(CV12)、上脘(CV13)、合谷(LI4)、内关(PC6)、三阴交(SP6)、悬钟(GB39)、足三里(ST36)和上巨虚(ST37)。
  • EA 1和EA 2组患者从第1天至第4天或至疼痛缓解每日进行一次电针治疗。
  • 试验注册于ClinicalTrials.gov,ID:NCT03173222,注册日期2017年8月1日。

临床怎么用

  • 基于试验结果,电针可能用于急性胰腺炎患者减少疼痛的临床实践。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Previous studies have shown that electroacupuncture (EA) reduces the severity of acute pancreatitis. However, the effect of EA for pain relief in patients with acute pancreatitis has not been evaluated yet. The purpose of this study was to prove the efficacy of EA for pain relief in patients with acute pancreatitis compared with conventional treatment. METHODS: This study is a randomized, controlled, three-arm, parallel-group, multi-center trial. Patients diagnosed with acute pancreatitis are enrolled and randomly assigned to EA 1, EA 2, or a control group in a 1:1:1 ratio. All the enrolled patients basically receive the conventional standard-of-care therapy for acute pancreatitis. Local EA is given in group EA 1, while local with additional distal EA is given in group EA 2. Local EA includes two acupoints, Zhong Wan (CV12) and Shang Wan (CV13), located in the abdomen, while distal EA includes 12 peripheral acupoints, Zhong Wan (CV12), Shang Wan (CV13), He Gu (LI4), Nei Guan (PC6), San Yin Jiao (SP6), Xuan Zhong (GB39), Zu San Li (ST36), and Shang Ju Xu (ST37). The patients randomized to the EA 1 and EA 2 groups undergo one session of EA daily from day 1 until day 4, or until pain resolves. The primary endpoint is the Visual Analog Scale (VAS) change for pain on day 5. Secondary endpoints include daily VAS, requirement of analgesics, changes of inflammatory markers, time to pain disappearance, and hospital days. DISCUSSION: The results of this trial are expected to prove the efficacy of EA for pain relief in patients with acute pancreatitis. Based upon the results, EA would be applied to a variety of clinical practices for reducing pain. TRIAL REGISTRATION: This trial is registered at ClinicalTrials.gov, ID: NCT03173222 . Registered on 1 August 2017.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Jang DK, Jung CY, Kim KH, et al. Electroacupuncture for abdominal pain relief in patients with acute pancreatitis: study protocol for a randomized controlled trial. Trials. 2018. PMID: 29769133. doi:10.1186/s13063-018-2644-1

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。